3-Year Supporting Data on TAVI in Low-Risk Patients: EVOLUT

Published Date: 08 Mar 2023

3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery

Read Full News

Latest News

Eleven New Molecular Targets Expand Treatment Options

Eleven new molecular drug targets receive approval in 2025, expanding treatment options for rare diseases, cancer, and infectious diseases.

Can Europe Keep Its Medicines Cool in 40 °C+ Summers?

As European heat waves shatter records, aging clinical infrastructure and lack of funding leave lifesaving, temperature-sensitive drugs vulnerable to degradation.

How to Prepare Patients for Exotic Travel: 10 Tips for GPs

From pretravel counseling to vaccinations, prophylaxis, and environmental precautions, here is how general practitioners can help travelers reduce risks before and during their trip.

Infections May Raise Long-Term Risk for Chronic Disease

Experts say infections are an underrecognized driver of chronic disease, with inflammation helping fuel cardiovascular, renal, and neurologic risks.

Coronary Microvascular Disease: Is There a Genetic Link?

A genome-wide association study links genetic variants to reduced coronary flow reserve, implicating the nuclear factor kappa B pathway in coronary microvascular disease.

Updated Heart Failure Definition Loosens LVEF Cutoffs

Leading cardiovascular societies have developed the second universal definition of heart failure that updates how it is classified and identified, hoping to improve diagnosis and management.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Latest News

Eleven new molecular drug targets receive approval in 2025, expanding treatment options for rare diseases, cancer, and infectious diseases.

As European heat waves shatter records, aging clinical infrastructure and lack of funding leave lifesaving, temperature-sensitive drugs vulnerable to degradation.

From pretravel counseling to vaccinations, prophylaxis, and environmental precautions, here is how general practitioners can help travelers reduce risks before and during their trip.

Experts say infections are an underrecognized driver of chronic disease, with inflammation helping fuel cardiovascular, renal, and neurologic risks.

A genome-wide association study links genetic variants to reduced coronary flow reserve, implicating the nuclear factor kappa B pathway in coronary microvascular disease.

Leading cardiovascular societies have developed the second universal definition of heart failure that updates how it is classified and identified, hoping to improve diagnosis and management.

News All Time

Rapid US Aging Ups Need for Minimally Invasive Care and AI

Aging Baby Boomers have brought cardiology to a critical juncture, fueling demand for minimally invasive procedures and AI tools to help meet the nuanced needs of older patients.

Women and Diabetes: Is Care Keeping Pace With Biology?

Hormonal changes throughout a woman’s life influence insulin needs, glucose regulation, and cardiovascular risk, highlighting the need for individualized diabetes care.

5 Heat Safety Tips for Patients With Heart Disease

High temperatures can quickly destabilize patients with cardiovascular disease, making clear, office-ready advice especially important during summer.

Screen All With Diabetes for Peripheral Vascular Disease?

Two speakers debated this question at the recent American Diabetes Association Scientific Sessions.

Study Probes Absolute Risk for ION With GLP-1 Agents

In patients with type 2 diabetes, GLP-1 RAs may be associated with a higher incidence of ischemic optic neuropathy than other medications, claims data show.

Simplified Score Improves Legionella Detection

Among patients with community-acquired pneumonia, a simplified five-predictor SwissLEGIO score rules out Legionnaires disease with high sensitivity, outperforming a widely cited score.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Dental Preset for CTA Best Minimises Knee Implant Artefacts

A dental reconstruction setting provides the strongest reduction in metal artefacts during photon-counting CT angiography of the lower leg among patients with total knee replacements.

New Wearable Ultrasound Pacemaker Works Outside the Body

A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for pacemakers without implantation.

Pharmacist-Led Drug Management for HFrEF Cost Effective

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart failure with reduced ejection fraction.

Do Weight-Loss Drugs Improve Heart Health, Quality of Life?

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

Warnings Strengthened on Alopecia Areata Medicine Litfulo

The drug should be used in certain patients only if suitable treatment alternatives are not available.

Muscle-Fat Index Predicts Risks for Heart Failure, Mortality

An imaging-derived muscle-fat index predicts heart failure, cardiovascular deaths, and all-cause deaths more accurately than BMI and waist-based measures.

Bioprosthetic Valves Tied to More Deliveries in Young Women

Bioprosthetic valves are associated with favorable delivery outcomes among women of childbearing age who undergo aortic valve replacement, a study finds.

Age Affects Survival and Complications After HeartMate 3

Outcomes of the HeartMate 3 device vary by age, with younger patients showing better survival and less bleeding events and older patients having more infections.

The Biology of a Broken Heart

Severe grief can trigger Takotsubo syndrome, a stress-induced heart failure that mimics a heart attack and may raise both short- and long-term mortality risk.

Recommended News For You

Fighting for others: How guilt and obligation drive desire for more intensive treatments in end-of-life cancer care

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Urinary tract cancer prediction models with high sensitivity and specificity

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

Recommended Articles For You

Gut microbiota in curing cancer 

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management 

Understanding Granulosa Cell Tumors: Symptoms, Diagnosis, and Treatments" 

Multidisciplinary Lessons from a Cancer of Unknown Primary 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.

2.

Updates from the 2022 WHO classification of kidney epithelial tumors

3.

Unlocking the potential of targeted therapies for multiple myeloma

4.

Nasal therapeutic HPV vaccine could prevent cervical cancer

5.

For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.

1.

The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring

2.

Emerging Methods in Hematology in Clinical Decision-Making

3.

Omentum Cancer: Causes, Symptoms, and Treatment Options

4.

Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence

5.

Contemporary Pathways in Hematology and Patient Outcomes

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

2.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Navigating the Complexities of Ph Negative ALL - Part VI

5.

Efficient Management of First line ALK-rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot